Side-by-side financials for ACXP and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACXP | NVS |
|---|---|---|
| Market cap | - | $283.13 B |
| US-listed rank | - | #47 |
| Net income (latest FY) | -$7.97M | - |
| SEC filings | 232 | 947 |
Full pages: Acurx Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.